CASE STUDY: STRATEGIC NARRATIVE
CASE STUDY: STRATEGIC NARRATIVE
The Story Was Nearly There.
The Clock Was Running.
The Story Was Nearly There.
The Clock Was Running.
The Story Was Nearly There.
The Clock Was Running.
How a focused narrative engagement helped an early-stage life sciences company close an oversubscribed seed round, on deadline.
How a focused narrative engagement helped an early-stage life sciences company close an oversubscribed seed round, on deadline.
The Situation
The Situation
The CEO of an early-stage life sciences company reached out to i5 BioPartners at a moment of real urgency. A seed funding round was already in motion, one the company needed not just to grow, but to grow on a specific timeline. The round was tied to a government-matched funding program that required the company to secure private investment within a fixed window. Miss the window, and the match would not be available. The stakes extended well beyond the immediate raise: the capital was earmarked to build out manufacturing capabilities and expand the team, both critical to the company's next stage of development.
The CEO of an early-stage life sciences company reached out to i5 BioPartners at a moment of real urgency. A seed funding round was already in motion, one the company needed not just to grow, but to grow on a specific timeline. The round was tied to a government-matched funding program that required the company to secure private investment within a fixed window. Miss the window, and the match would not be available. The stakes extended well beyond the immediate raise: the capital was earmarked to build out manufacturing capabilities and expand the team, both critical to the company's next stage of development.
What the Engagement Required
What the Engagement Required
A typical communications engagement, months of workshops, drafts, and iterations, was not an option. i5 BioPartners ran two core programs in sequence. First, the Strategic Narrative engagement: a focused two-hour session with the founding team that drew out the story already embedded in their work and structured it across the six dimensions of the i5 Bio narrative arc. The result was a complete Strategic Narrative Report, the company's market context, the problem it solves, the best case it enables, and the evidence that makes it investable, all in language the founders could own and investors could act on.
With the narrative established, the team moved directly into a full review and rebuild of the pitch deck. Every slide was evaluated against the narrative arc. Structure, sequencing, and language were revised to reflect the clarity the narrative had produced.
A typical communications engagement, months of workshops, drafts, and iterations, was not an option. i5 BioPartners ran two core programs in sequence. First, the Strategic Narrative engagement: a focused two-hour session with the founding team that drew out the story already embedded in their work and structured it across the six dimensions of the i5 Bio narrative arc. The result was a complete Strategic Narrative Report, the company's market context, the problem it solves, the best case it enables, and the evidence that makes it investable, all in language the founders could own and investors could act on.
With the narrative established, the team moved directly into a full review and rebuild of the pitch deck. Every slide was evaluated against the narrative arc. Structure, sequencing, and language were revised to reflect the clarity the narrative had produced.
"The team is clearly familiar with the life sciences space and was able to meet our tight deadlines on a project that was critical to our funding cycle." - CEO, Early-Stage Life Sciences Company
Why Narrative Before the Deck
Why Narrative Before the Deck
Most pitch deck work starts from the slides, adjusting language, improving visuals, tightening bullet points. That approach optimizes the container without addressing what goes inside it. When the underlying narrative is unclear, no amount of slide design produces a pitch that investors find compelling.
The i5 Bio Strategic Narrative engagement works in the opposite direction. It starts with the world the company operates in, the forces making the problem urgent, the consequences of leaving it unaddressed, the obstacles that have prevented others from solving it, and builds inward to the solution and its evidence base. The narrative arc that emerges is not a list of talking points, but a connected story with logical momentum that an investor can follow and a founder can own.
Most pitch deck work starts from the slides, adjusting language, improving visuals, tightening bullet points. That approach optimizes the container without addressing what goes inside it. When the underlying narrative is unclear, no amount of slide design produces a pitch that investors find compelling.
The i5 Bio Strategic Narrative engagement works in the opposite direction. It starts with the world the company operates in, the forces making the problem urgent, the consequences of leaving it unaddressed, the obstacles that have prevented others from solving it, and builds inward to the solution and its evidence base. The narrative arc that emerges is not a list of talking points, but a connected story with logical momentum that an investor can follow and a founder can own.
The Outcome
The Outcome
The seed round closed oversubscribed. The company met the government matched-funding deadline, securing a program it could not have accessed without closing private investment on time. The capital will fund the manufacturing build-out and team expansion, both now moving forward on schedule.
The Strategic Narrative Report is also continuing to work. Built from the founders' own language and structured to adapt across audiences, it is already serving as the foundation for the company's broader marketing program, the next phase of the i5 Bio engagement now underway.
The seed round closed oversubscribed. The company met the government matched-funding deadline, securing a program it could not have accessed without closing private investment on time. The capital will fund the manufacturing build-out and team expansion, both now moving forward on schedule.
The Strategic Narrative Report is also continuing to work. Built from the founders' own language and structured to adapt across audiences, it is already serving as the foundation for the company's broader marketing program, the next phase of the i5 Bio engagement now underway.
What this Demonstrates
What this Demonstrates
Narrative is the foundation, not the finish line. Pitch materials built on a clear strategic narrative are fundamentally different from those built on slide-by-slide revision. The narrative gives every piece of investor communication a consistent logic to draw from.
Speed and quality are not in conflict. A focused two-hour session produced a complete Strategic Narrative Report in days and an updated deck in just two weeks. The company did not have to choose between getting it done and getting it right.
A funded company is not the end of the story. The narrative built for investors becomes the foundation for customer communication, team alignment, and market positioning. Clarity compounds across every audience the company needs to reach.
Narrative is the foundation, not the finish line. Pitch materials built on a clear strategic narrative are fundamentally different from those built on slide-by-slide revision. The narrative gives every piece of investor communication a consistent logic to draw from.
Speed and quality are not in conflict. A focused two-hour session produced a complete Strategic Narrative Report in days and an updated deck in just two weeks. The company did not have to choose between getting it done and getting it right.
A funded company is not the end of the story. The narrative built for investors becomes the foundation for customer communication, team alignment, and market positioning. Clarity compounds across every audience the company needs to reach.
SUMMARY
Client
Early-stage life sciences company pursuing a seed round tied to a government-matched funding program with a fixed closing deadline.
Early-stage life sciences company pursuing a seed round tied to a government-matched funding program with a fixed closing deadline.
Challenge
Strong science, genuine traction, but no structured narrative to communicate the opportunity clearly to investors under a tight deadline.
Strong science, genuine traction, but no structured narrative to communicate the opportunity clearly to investors under a tight deadline.
Solution
Strategic Narrative engagement and a full pitch deck review and rebuild, delivered in rapid sequence.
Strategic Narrative engagement and a full pitch deck review and rebuild, delivered in rapid sequence.
Result
Seed round closed oversubscribed. Government-matched funding window met.
Seed round closed oversubscribed. Government-matched funding window met.
SERVICES DELIVERED
Strategic Narrative
A two-hour session structured the company's story across six dimensions: market shift, consequences, best case, obstacles, solution, and evidence. Delivered as a complete Strategic Narrative Report within days.
A two-hour session structured the company's story across six dimensions: market shift, consequences, best case, obstacles, solution, and evidence. Delivered as a complete Strategic Narrative Report within days.
Pitch Deck Review & Rebuild
Early-stage life sciences company pursuing a seed round tied to a government-matched funding program with a fixed closing deadline.
Early-stage life sciences company pursuing a seed round tied to a government-matched funding program with a fixed closing deadline.
OUTCOME
Over-subscribed
Over-subscribed
Seed Round Outcome
2
Core Programs Delivered
15 Days
From workshop to completed Strategic Narrative Report
"The story was already there. We just needed the right structure to make it investable."
Let's create your narrative together!
Impact Areas
Resources
Search i5 Bio
Search
Copyright © 2025 – All Right Reserved